Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,366 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07871513RecruitingPhase 2
Facial line treatment with two botulinum toxins
This study tests a new combination of two botulinum toxin types (trenibotulinumtoxinE and onabotulinumtoxinA, commonly known as Botox) for treating moderate to severe frown lines between the eyebrows. It aims to see if the combination is safe and works well.
Glendale, ArizonaAges 18 years+ - NCT07128199RecruitingPhase 3
Zipalertinib after surgery for early-stage lung cancer with uncommon EGFR mutations
This study tests whether taking zipalertinib after lung cancer surgery can help prevent the cancer from coming back in people whose tumors have uncommon EGFR gene changes. It is a pill taken daily after recovery from surgery.
Anchorage, AlaskaAges 18 years+ - NCT07871487Recruiting
Brain protein changes after hip or knee replacement surgery
This study looks at whether having hip or knee replacement surgery with spinal anesthesia affects certain proteins in the brain that are linked to memory and thinking. It compares people having surgery with people who have arthritis but are not having surgery, to help understand if the surgery causes any short-term brain changes.
UppsalaAges 55–75 - NCT07854392RecruitingPhase 4
Testing a new flu shot in healthy adults
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
Shaoxing, ZhejiangAges 18–59 - NCT07832188Recruiting
Brain stimulation for chronic lower back pain
This study tests a non-invasive brain stimulation technique that uses gentle electrical currents to target the part of the brain involved in pain processing. It may help reduce chronic lower back pain that is not caused by a specific injury or condition.
Jinan, ShandongAges 18–80 - NCT07872553RecruitingEarly Phase 1
Kidney cancer treatment preference study
This study looks at how kidney cancer patients feel about getting their treatment at home versus at the clinic, and asks their doctors for their views too. It is for patients already on certain standard treatments and aims to understand preferences that may improve care.
Basking Ridge, New JerseyAges 18 years+ - NCT07831876RecruitingPhase 1
Ear nerve stimulation for eye inflammation
This study tests whether gently stimulating a nerve in the ear can help reduce swelling or irritation in the eyes. It may offer a new drug-free way to treat certain types of eye inflammation.
Basking Ridge, New JerseyAges 18 years+ - NCT07831681Recruiting
A therapeutic game for teens with psychotic symptoms
This trial tests whether a collaborative video game can help reduce psychiatric symptoms like delusions and hallucinations in teenagers. It may also help with rigid thinking, and could be a new way to support mental health during outpatient care.
RennesAges 12–17 - NCT07831213Recruiting
Safety and performance study of a lip filler
This study is testing a new lip filler to see if it works well and is safe. It may help people who want to improve the look of their lips.
Lod, IsraelAges 18 years+ - NCT03432806Recruiting
Looking at tissue samples to guide colon cancer treatment
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
Basking Ridge, New JerseyAges 18 years+ - NCT07687459RecruitingPhase 3
Oral treatment for idiopathic pulmonary fibrosis
This trial tests an experimental pill called rentosertib for people with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring. The study aims to see if the drug can slow down the disease and improve breathing.
Hefei, AnhuiAges 40 years+ - NCT07822269Recruiting
Magnifying tools for deep teeth cleaning
This study compares two types of magnifying tools used during deep cleaning of teeth and gums. It aims to see if one tool is better at removing plaque and tartar, which may help treat gum disease.
AnkaraAges 18 years+ - NCT07872202Recruiting
Parkinson's rehabilitation and independence study
This study looks at how rehabilitation can help people with Parkinson's disease become more independent and improve their symptoms. It aims to see if specific exercises can make daily tasks easier and improve quality of life.
OlomoucAges 50–80 - NCT07804056RecruitingPhase 3
Alpha1H before surgery for low-risk bladder cancer
This study tests a new medicine called Alpha1H that is given before the usual surgery to remove bladder cancer. It may help lower the risk of the cancer coming back.
PragueAges 18 years+ - NCT07802717RecruitingPhase 1
CAR T cell therapy for returning multiple myeloma
This trial tests a new treatment called VV169, a type of CAR T cell therapy, for people with multiple myeloma that has returned or stopped responding to previous treatments. The goal is to see if it is safe and if it can help fight the cancer.
Rochester, MinnesotaAges 18 years+ - NCT07799402Recruiting
How gut and brain health change with age
This study looks at how the bacteria in your gut are linked to brain health as you age. It includes people with normal memory, mild memory problems, or Alzheimer's disease, and aims to find ways to keep brains healthy as we get older.
Tampa, FloridaAges 18 years+ - NCT07789106Recruiting
CoQ10 for fatigue and strength in GLP-1 users
This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.
GlasgowAges 30–65 - NCT07750158RecruitingPhase 3
Zanzalintinib for colorectal cancer with residual tumor dna
This trial is testing a new drug (zanzalintinib) alone or with pembrolizumab to see if it can stop cancer from coming back in people with colorectal cancer who have no visible cancer on scans but still have tumor DNA in their blood.
Council Bluffs, IowaAges 18 years+ - NCT07693751RecruitingPhase 1/Phase 2
Testing a new drug for advanced colorectal cancer
This trial tests a new drug called SOT109 for people with advanced colorectal cancer that can't be removed by surgery or has spread. The goal is to see if it is safe, how well it works, and how the body handles it.
Houston, TexasAges 18 years+ - NCT06084416RecruitingPhase 1
Pill study for advanced ovarian cancer that resists chemo
This trial tests an experimental drug called sovilnesib (taken as a pill) for people with advanced ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum chemo. The goal is to see if this drug can shrink or slow the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07606365RecruitingPhase 2
Testing a New Treatment for Geographic Atrophy
This study tests a new drug called STL303 for geographic atrophy, a condition where the back of the eye slowly loses cells, causing vision loss. The drug aims to slow or stop this vision loss in people over 60.
Bakersfield, CaliforniaAges 60 years+ - NCT07602283Recruiting
Music to Help with Pain and Memory Problems
This study tests whether listening to music can help reduce pain and improve thinking in people with early memory loss or mild dementia. Researchers will monitor brain activity, heart rate, and pain levels while you or your loved one participate in music sessions.
New Haven, ConnecticutAges 50–80 - NCT07598396RecruitingPhase 2
Mosunetuzumab for systemic lupus erythematosus treatment
This study tests a new drug called mosunetuzumab in people with systemic lupus erythematosus (SLE), a disease where the immune system attacks the body's own tissues. The drug is designed to help control the immune response and reduce lupus symptoms, including kidney involvement if present.
Salvador, Estado de BahiaAges 18 years+ - NCT07546812RecruitingPhase 2
Testing Denikitug for advanced stomach and esophageal cancer
This study tests a new drug called denikitug, alone or combined with other cancer treatments, for patients with advanced stomach, gastroesophageal junction, or esophageal adenocarcinoma that has progressed after initial treatment. The drug targets immune cells to help your body fight cancer.
Boston, MassachusettsAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,366 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.